The stoichiometry of the subunits that comprise the T cell antigen receptor (TCR) complex is not completely known. In particular, it is uncertain whether TCR ot and TCR/5 proteins are present in the TCR complex as one or multiple heterodimeric pairs. In this study we have used mice transgenic for two different TCR ot and two different TCR/5 proteins to determine the number of TCR a and TCR/5 chains in a single TCR complex. Individual thymocytes and splenic T cells from double TCR transgenic mice simultaneously expressed all four transgenic TCR proteins on their surfaces. Because the individual TCR ot and individual TCR/5 proteins were biochemically distinguishable, we were able to examine associations among the transgenic TCR products. We found that each TCR ct chain paired with each TCR/5 chain, but that each TCR complex contained only one TCR ot and one TCR B protein. Furthermore, quantitative immunofluorescence revealed that T cells expressed twice as many CD3e as TCR/5 proteins. These findings demonstrate that there are precisely one TCR a, one TCR/5, and two CD3e chains in each TCR/CD3 complex expressed on the surfaces of both thymocytes and mature T cells.
T
he TCR, a heterodimer of ot and/5 proteins, is expressed on the surface oft lymphocytes as part ofa multisubunit complex that includes the CD3 proteins (CD33,, tS, and e) and a dimer of the ~'protein family (1) . Although all members of the surface TCR/CD3 complex have been identified, their stoichiometry has not yet been completely determined. Recent studies showing that at least two, and possibly only two, CD3e proteins are present per TCR/CD3 complex have led to a reevaluation of TCR/CD3 structure and the proposal that CD3 components exist in a single complex as two dimers of 3'/e and ~/~ proteins (2) (3) (4) . Several groups have also raised the possibility that there are two TCR a and two TCR chains in a single TCR complex (5, 6) , arguing that such an arrangement would facilitate signal transduction after TCR engagement by antigen and would result in an electrostatically neutral and, hence, more stable protein complex.
To determine whether there were more than one TCR ot or TCR/3 protein in a single TCR/CD3 complex, we examined associations among components of surface TCR on thymocytes and splenic T cells coexpressing two different TCR ot and two different TCR ~ chains. The results of these experiments provide a unique solution to the stoichiometry of the TCR/CD3 complex and demonstrate that there are only one TCR ot chain, one TCR ~ chain, and two CD3 e chains in a single TCR/CD3 complex.
Materials and Methods
Mice. Mice transgenic for the AND TCR ot and/~ chains (7) were originally provided by S. Hedrick (University of California at San Diego, La Jolla, CA) and were bred in our facility. They had been backcrossed for more than 10 generations onto a C57BL/6-LyS.2 background. Mice transgenic for the anti-H-Y TCR a and /~ chains (8) were originally provided by H. von Boehmer (Basel Institute, Basel, Switzerland) and were bred in our facility. Double transgenic mice were generated by crossing a mouse heterozygous for the AND transgenes with a mouse heterozygous for the anti-H-Y transgenes. Progeny were screened for the expression of transgenic TCR products by examining PBL for surface expression of the AND TCR ct (ANDVc~11) and the anti-H-Y TCR/3 ("-vVa8) chains. Female single and double TCR transgenic animals were used in these studies.
Antibodies. Biotinylated mAbs anti-V~11 (RR8-1 [9] ) and antiVa3 (KJ-25 [10] ) are specific for the AND TCR cr and TCR/~ chains, respectively, were purchased from PharMingen (San Diego, CA). T3.70, the mAb specific for the anti-H-Y TCR ot chain V~3, was provided by H. von Boehmer (8) and conjugated to FITC in our lab. mAb anti-Va8.1, 8.2, 8.3 (F23.1 [11] ) binds the anti-H-Y TCR ~ chain and was purified and conjugated to FITC in our lab. mAb anti-CD3e (145-2Cll [12] ) was used as a hybridoma supernatant for precipitations and as a protein A-purified preparation for quantitative surface staining. Both mAb anti-CD3e (500A2 [13] ) and mAb anti-TCR B (H57-597 [14] ) were also used as protein A-purified preparations for quantitative surface staining.
Cells. Thymi were dissected from young adult (6-8 wk) mice.
Single cell suspensions of thymocytes were prepared by gently teasing cells from the thymic capsule and filtering over nylon mesh. Splenic T ceils were prepared by panning murine splenocytes on plates coated with rabbit anti-mouse Ig (Organon Teknika, Durham, NC) to rid the population of B cells and adherent ceils. Splenic CD4 + (CDS-depleted) T cells were prepared from C57BL/6 mice by further treating the cells with anti-CD8 (3.155 [15] ), anti-NKl.1 (PK136 [16] ), anti-I-A b' d,q (M5/114.15.2 [17] ) and rabbit complement for 30 min at 370C, and then with rabbit complement alone for another 30 rain at 37~ Viable cells were collected after centrifugation over Lympholyte-M (Cedarlane Laboratories, Ltd., Hornby, Canada).
Staining. Murine thymocytes and splenic T calls (5 x l0 s)
were stained with saturating concentrations of biotinylated and FITC-conjugated reagents in 40 #1 for 30 min at 40C, washed in 200 #1 staining medium (HBSS, 0.1% BSA, 0.1% NAN3) three times, then stained in 40 #1 with saturating concentrations of Texas Red streptavidin for 15 min at 40C. Cells were washed again and analyzed on a FACStar Plus | (Becton Dickinson & Co., Mountain View, CA). For quantitative immunofluorescence of splenic T cells, 106 cells were washed and incubated at 40C for 1 h with unlabeled anti-TCK fl (H57-597), unlabeled anti-CD3e (145-2Cll or 500A2) at concentrations determined empirically to be saturating (0.5 #g/ml for H57-597, 0.25 #g/ml for 145-2Cll, and 1.0 #g/ml for 500A2). Because these antibodies share the same isotype (hamster IgG), their relative binding intensities could be compared directly. After extensive washing, bound antibodies were visualized with FITC-conjugated goat anti-hamster antibody, which was also used at saturating concentrations.
Surface Ioaination, Immunoprecipitation, and Endoglycosidase-F (Endoy F Digestion. Cells were pelleted, washed with cold PBS and treated with Bolton Hunter reagent (18) before they were surface iodinated as described previously (19) . Surface iodinated cells were lysed in 1% digitonin as described previously (19) and immunoprecipitated with beads preadsorbed to fetal calf serum, then with beads preadsorbed to 2-4 #g purified antibody (anti-V~11, antiVa3) or 1 ml hybridoma supematant (F23.1, T3.70, and 2Cll). Immunoprecipitates were washed in buffer containing 0.2% digitonin (18) and digested overnight with Endo F/Peptide-NGlycosidase F (Endo F/PNGase F) (Oxford Glycosystems, Rosedale, NY) at 37~ as per the manufacturer's instructions.
Two-dimensional NEPHGE/SDS-PAGE Electrophoresis.
Immunoprecipitated samples were equih'brated in 150 #1 sample buffer (9.5 M urea, 2% Triton X-100, 1.6% Ampholyte 5-7 [Bio-Rad Laboratories, Richmond, CA], 0.4% Ampholyte 3-10 [Bio-Rad Laboratories], 5% 2-mercaptoethanol) and separated in tube gds across a pH gradient (nonequilibrium pH gradient electrophoresis [NEPHGE]) for 2500 volt-hours as described previously (18, 20) . Tube gels were extruded, equilibrated at 37~ in SDS-PAGE sample buffer containing 2-mercaptoethanol and run in the second dimension on a 13% reducing PAGE gel. Gels were run for 865 Vh, fixed, dried, and visualized by phosphorimagery.
Results
Experimental Design. The stoichiometry of the TCR/CD3 complex has not yet been solved and a number of TCR/CD3 configurations are consistent with current data (Fig. 1 ). Vat- ious solutions differ by the number of TCK c~ and B chains present per complex and the ratio between the moles of TCK fl (or TCR c~) and CD3 e represented in each complex. Models proposing more than one TCR ot and TCK/~ in a single complex predict that, on a cell expressing two different TCR ot chains, antibodies specific for one TCR c~ would coprecipitate the other TCR a. Similarly, on cells expressing two different TCK/3 chains, antibodies specific for one TCK/3 would coprecipitate the other TCR/3 chain. In the present study, we have tested this prediction by generating cells that coexpressed two different TCK ot and two different/3 chains on their surfaces and have examined associations among complex components. The usefulness of such an approach, however, required that the two different TCR ot and two different TCK/3 proteins be biochemically distinguishable. chains (^NDV~ll and H-W~3) nor the AND and H-Y TCR /3 chains (^NDVa3 and a-YVa8 ) could be distinguished by molecular weight or charge (data not shown). However, when stripped of their carbohydrate side chains with Endo F/PNGase F, which hydrolyze N-linked sugar residues, and then separated by charge, the two ot chains and the two/3 chains exhibited unique migration patterns when resolved by twodimensional NEPHGE under reducing conditions (Fig. 2) . The ^NDV~ll chain migrated as two spots, designated all1 and cd12 (Fig. 2) and the H-vV~3 chain migrated as a significantly more acidic single spot, designated ~3. The ANDV/~3 chain migrated as two major spots, designated/33t and fl32, as did the "-YV~8 chain, designated/38t and/382. The/382 spot generated by H-vVa8 was significantly lower in molecular weight than any spot generated by ^NDVa3.
The AND TCR oe and TCR ~ Chains Are Biochemically Distinguishable from the H-Y TCR ce and TCR ~ Chains.
Most importantly, the two TCR o~ and the two TCR/3 chains were distinguishable from each other when anti-TCR ol or anti-TCR/3 precipitations from AND and H-Y thymocytes were mixed together before NEPHGE analysis. In particular, the appearance of the c~3 and/382 spots, unique to H-YV~3 and H-vVo8, respectively, provided unambiguous evidence for the presence of the H-Y transgene products in immunoprecipitated preparations (Fig. 2) .
AND (Fig. 3) . Surface staining revealed that the large majority of thymocytes in double transgenic mice bound antibodies to both ^NDVa3 and H-YV/~8 as well as both ^NDVa11 and H-YVa3 (Fig. 3 , bottom left). Immunoprecipitations supported the indication that AND and H-Y TCR proteins were expressed on the surface of the same cells. Antibodies to ANDV,,11 coprecipitated both ANDVa3 and H-YV~8, as shown by the appearance of the ~31, ~32, and the spot unique to H-Y, B82 (Fig. 4 A, left , see arrow to the right). Reciprocally, ANDV~3 coprecipitated both ANDV~11 and H-YV~,3 from double TCR transgenic thymocytes, as indicated by the presence of the ot111, c~112, and the spot unique to H-Y, or3 (Fig. 4 A, middle, see arrow on the left). Hence, TCR ot and TCR B chains of different transgenic origins shared the same receptor complex, indicating (a) that they were expressed on the surface of the same cell and (b) that the two transgenic TCP,, ot chains could freely associate with each of the two transgenic TCR ~ chains.
Thymocytes and Splenic T Cells Express Only One TCR ce and one TCR ~ per TCR/CD3
Complex. As expected, antiCD3e (2Cll) coprecipitated both ANDVa3 and ANDV~11 from single AND transgenic thymocytes and precipitated both "-YV~8 and "-YV,,3 from single H-Y transgenic thymocytes. Anti-CD3E also coprecipitated all transgenic TCR chains from the surface of AND/H-Y double transgenic thymocytes as indicated by the presence of ~81 and B82 spots and by the presence of o~111, ol112, and c~3 spots (Fig. 4 A, right) .
Although the AND TCR B and the H-Y TCR ~ chains associated with both transgenic TCR c~ chains and with CD3e, they never associated with each other. Antibodies to ANDV,~11 failed to coprecipitate H-YV~3 from the surface of double transgenic thymocytes, for the spot unique to H-YV,~3, i.e., c~3, was absent after NEPHGE analysis (Fig.  4 A, left, left arrow) Anti-H-vv~3 (T3.70) also failed to precipitate spots unique to ANDV~ll (data not shown). Similarly, the two transgenic TCR/~ chains did not associate with each other, for anti-ANnV~3 failed to precipitate the spot unique to "-YV~8, i.e., ~82 (Fig. 4 A, middle, right arrow) .
Thus, these data indicated that ANDVall and H-YVa3 were both expressed on the surface of double transgenic thymocytes but were not present in the same complex. Likewise, both ANDV~3 and H-YV~8 were present on the surface of double TCR transgenic thymocytes, but were not present in the same complex. Therefore, each TCR complex expressed by double TCK transgenic thymocytes contained only one TCK o~ and one TCR fl chain.
To address the possibility that stoichiometry of TCR complexes differed between immature and mature T cells, we examined the associations of transgenic TCR ex chains expressed by splenic T cells from single (AND) and double (AND/ H-Y) transgenic mice (Fig. 4 B) . Anti-V~11 precipitated ANDv~11 from the surfaces of both AND single transgenic and AND/H-Y double transgenic splenic T lysates, as shown by the appearance of spots ot111 and ex112. However, anti-V~11 did not coprecipitate H-YV~3, for the or3 spot was absent by NEPHGE analysis. As was observed in thymocytes, these findings demonstrate that ANDVall was not present in the same TCR complex that contained H-YV~3. We conclude that there is only one TCK cx per complex expressed by mature T cells.
The TCR/CD3 Complex Contains One TCR or, One TCR ~, and Two CD3e Proteins. Our findings rule out models of TCR/CD3 stoichiometry that propose more than one TCR ot and one TCR ~ chain per complex (Fig. 1, B and C) and also predict that CD3e chains outnumber TCR ~ chains on the surface of T cells (Fig. 1 A) . To quantify the relative expression levels of CD3e and TCR B proteins on normal T cells, we compared the densities of TCR B and CD3e on normal splenic T cells by immunofluorescence. When incubated with saturating concentrations of anti-TCR. B (H57-597) or with saturating concentrations of two different anti-CD3E antibodies (either 145-2Cll or 500A2), all of which share the Spleen T IOglo fluorescence same isotype (hamster IgG) and subsequently incubated with the same fluorescently tagged secondary antibody (goat anti-hamster IgG), splenic T cells stained with anti-CD3e fluoresced with greater intensity than those stained with anti-TCR/3 (Fig. 5) . When total fluorescence units were compared, precisely twice as much anti-CD3e bound the surface of splenic T cells as anti-TCR/3, indicating that CD3e and TCR/3 were present at a 2:1 ratio on the T cell surface.
Discussion
In the present study we assessed the stoichiometry of the TCR ot and TCR fl chains in the TCR/CD3 complex expressed on the surface of immature and mature T cells. When associations between different TCR ex and different TCR/3 chains of T lymphocytes from mice transgenic for two different TCR cx//3 heterodimers were examined, it was dear that each of the transgenic TCR c~ proteins freely associated with each transgenic TCR/3 protein, and vice versa. However, no more than one TCR ot and TCR/3 was ever detected in a single TCR complex. Antibodies specific for one transgenic TCR ot chain never coprecipitated the other transgenic TCR ot chain and, reciprocally, antibodies against one transgenic TCR/3 chain never coprecipitated the other transgenic TCR/3 chain. The absence of any association between either the transgenic TCR oe protein or the transgenic TCR/3 chains directly rules out the existence of TCR complexes containing multiple independent TCR cx//3 pairs. The present data even rule out models that postulate TCR complexes containing multiple TCR ee//3 pairs where different individual TCR. ot or different individual TCR/3 chains are constrained from sharing the same complex. For example, even if the two transgenic TCR r proteins ("-vV~3 and ^NDV,dl) were constrained from sharing a single complex, each anti-Vt~ antibody would have coprecipitated the other transgenic TCR 3 protein because each transgenic TCR ot chain paired freely with both transgenic TCR/3 chains. Similarly, if the two transgenic TCR /3 proteins ("-eVa8 and ^NDVa3) were incompatible, each anti-V~ antibody would have coprecipitated the other transgenic TCR c~ protein because each transgenic TCR/3 chain paired freely with both transgenic TCR r chains. The only possibility that our data do not preclude is that TCR complexes on double transgenic mice exclusively contain multiple identical TCR or//3 pairs. Such a possibility would require V-region incompatibilities not only between the two transgenic TCR cz proteins in different disulfide linked cx/3 dimers, but also between the two transgenic TCR/3 proteins. It is difficult to imagine a physical basis for such a severe constraint. Thus, we conclude that each TCR complex contains only one TCR ot and one TCR/3 chain (Fig. 1 A) .
Quantitative surface staining further demonstrates that CD3e and TCR/3 are expressed on the surface of normal T cells at a 2:1 ratio, as proposed in Fig. 1 A. Because the anti-CD3e antibody 2Cll recognizes CD3e in association with either CD3"y or CD3~, there are two e containing dimers per TCP, complex (2~/e, 26e, or one of each), a stoichiometry previously advocated by the data and conclusions of de la Hera et al. (4) . However, the precise stoichiometry of CD3& CD3% and ~" proteins still remains unknown. We cannot reconcile our data with studies suggesting that CD3e and TCR/3 are present on the surface of T cells in a 1:1 ratio (21, 22), since our immunofluorescent assessment clearly indicates that TCR B and CD3e proteins are present in a 1:2 ratio. Therefore, the present study demonstrates that there are precisely one TCR or, one TCR/3 and two CD3e proteins in a single TCK/CD3 complex.
What made it possible for us to assess associations between the two different TCK c~ and the two different TCR/3 chains in double transgenic mice were the distinctive patterns each transgenic protein generated after they were stripped of their N-linked oligosaccharides before NEPHGE analysis. Without Endo F/PNGase digestion, the TCK proteins were indistinguishable, although u-YV,,3 was slightly more acidic than ^NDV,dl (data not shown). Every transgenic TCR protein except "-vV~3 resolved into several spots after digestion. These biochemical signatures were remarkably reproducible and multiple additions of fresh Endo F/PNGase did not change the pattern of spots generated. The multiple spots formed by each TCR oe and TCR/3 chain during NEPHGE analysis presumably represent the variety of TCR protein products generated when mixed Endo F/PNGase activities act upon a pool of heterogeneously glycosylated TCK cx and/3 chains. It could also be a reflection of heterogeneity in accessibility of individual chains to Endo F/PNGase digestion.
The possibility that there were more than one TCR cx//3 heterodimer per complex was originally raised to account for a number of observations, the most compelling of which was the recognition that an c~/fl/e ratio of 1:1:2 would result in a transmembrane charge imbalance (5) . Because TCR c~ and TCK/3 chains have three positively charged transmembrane residues between them and the CD3 proteins and ~" chains each have one negatively charged transmembrane residue, a TCR/CD3 complex with one TCR ~//3, two CD3es, one ~" dimer, one CD3fi, and one CD37 would have a net charge of -3. It is possible that as yet unidentified proteins and/or lipids associate with the complex to maintain charge neutrality. A charge imbalance may, in fact, give the TCR/CD3 complex the flexibility to interact with different surface proteins at different times during activation or differentiation. Alternatively, arithmetric calculations of net charge may not take into account complexities introduced by tertiary structure which may mute the imbalance. It is also possible that charge neutrality is not critical for stability of surface proteins. Indeed, the neu oncogene product is stably expressed on the cell surface despite a net negative charge of -1 within its transmembrane domain (23) .
Our findings offer an explanation also proposed by de la Hera et al. (4) for data demonstrating a difference in the developmental and functional effects of anti-CD3e and anti-TCR B (24) (25) (26) (27) . Because there are two CD3e chains per complex, anti-CD3e is capable of aggregating multiple receptor complexes and generating intraceUular signals through multivalent cross-linking of TCR/CD3 components. However, because there is only one TCR/~ chain per TCR complex anti-TCR ~ can induce no more than bivalent TCR crosslinking. The signals transduced by bivalent rather than multivalent cross-linking may be quantitatively and qualitatively distinct.
